Skip to main content
Equibles
PFE logo

PFE · Pfizer Inc · Investor Relations

Track PFE — free

Use PFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$30.03 -0.39 (-1.28%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$171.16B
Shares
5.70B
Volume · Oct 23 29.48M Avg daily vol (3M) 34.46M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-03 15:00 UTC Pfizer Quarterly Corporate Performance - Third Quarter 2026 Event

Recent news

Date Headline
2026-10-24 Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
2026-10-14 Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
2026-10-07 Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
2026-10-06 Pfizer Declares Fourth-Quarter 2026 Dividend
2026-10-02 Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
2026-10-01 Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
2026-09-28 Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
2026-09-22 Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
2026-09-15 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2026-09-08 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
2026-08-27 Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
2026-08-14 Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
2026-08-04 Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
2026-07-30 Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
2026-07-29 European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
2026-07-22 FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
2026-07-10 U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
2026-06-24 Pfizer Declares Third-Quarter 2026 Dividend
2026-06-24 FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
2026-06-23 Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts
2026-06-22 Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
2026-06-18 Pfizer Announces Chief Financial Officer Transition
2026-06-08 U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
2026-06-06 Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
2026-06-01 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Past events

Date Event Type
2026-09-22 J.P. Morgan U.S. All Stars 2026 Conference Conference
2026-09-14 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-08-04 Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts Earnings call
2026-06-08 Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-06 Pfizer Pflash Live from ADA: A Spotlight on Obesity Event
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-05 Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts Earnings call
2026-05-05 PFE.N - Q1 2026 Pfizer Inc Earnings Call Earnings call
2026-04-23 2026 Pfizer Annual Meeting of Shareholders Shareholder meeting
2026-03-02 TD Cowen 46th Annual Health Care Conference Conference
2026-02-03 Q4 Earnings conference call (announced in 8-K) Earnings call
2026-02-03 PFE.N - Q4 2025 Pfizer Inc Earnings Call Earnings call
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-16 Pfizer Analyst and Investor Call to Review Pfizer Full-Year 2026 Financial Guidance Earnings call
2025-11-19 Jefferies London Healthcare Conference Conference
2025-11-10 Pfizer Pflash: A Spotlight on the PF’4404 (SSGJ-707 / PF-08634404) Clinical Development Strategy Event
2025-11-04 PFE.N - Q3 2025 Pfizer Inc Earnings Call Earnings call
2025-09-22 Pfizer Analyst and Investor Call to Discuss Proposed Acquisition of Metsera Event
2025-08-05 PFE.N - Q2 2025 Pfizer Inc Earnings Call Earnings call
2025-07-25 Pfizer Pflash: A Spotlight on the PD-1 x VEGF Bispecific Antibody Event
2025-06-12 Pfizer Pflash: A Spotlight on Pfizer's Breast Cancer Portfolio Event
2025-06-09 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-04-29 Pfizer Quarterly Corporate Performance - First Quarter 2025 Event
2025-04-29 PFE.N - Q1 2025 Pfizer Inc Earnings Call Earnings call
2025-04-24 Annual Meeting of Shareholders Shareholder meeting

Source: https://investors.pfizer.com/overview/default.aspx

Key facts CIK 78003 CUSIP 717081103 13F (30d) 927 filings 890 filers Visit website Investor relations